Sign up to save your podcasts
Or
Share Dr. Kasi: Thoracoabdominal - A Historic Approach, FEVAR Concepts & Pharmacogenomics Testing. Part 2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr. Kasi: Thoracoabdominal - A Historic Approach, FEVAR Concepts & Pharmacogenomics Testing. Part 2
We’re joined by board certified Vascular Surgeon, Dr. Karthikeshwar Kasirajan. Dr. Kasi is a clinical professor of surgery at the University of Stanford School of Medicine and has conducted research into advances in minimally invasive procedures for stroke prevention and aneurysm management. Dr. Kasi has been the investigator in over 40 multicenter studies involving new stent grafts, thrombectomy catheters, and other advances in endovascular technology. In this part two episode with Dr. Kasi we hear him address issues with lack of pharmacogenomics testing, and the specific drug that causes the most frequent ER visits due to drug complications which can be avoided with proper testing! Listen in as we wrap up this part 2 conversation with Dr. Kasi about thrombectomy devices, techniques, and business advice for the next generation of Vascular Surgeons.
01:30 Mentors at the Cleveland Clinic.
03:00 Learning it wasn’t the norm to do pharmacogenomics testing.
05:50 How Medicare will not reimburse testing.
07:00 What is the number 1 cause for ER visits due to drug complications?
11:40 The need for genetic testing.
14:15 What has your experience been like leading the industry from the stage, to journals and the Operating Room?
19:00 Evolution of thrombectomy devices, including some that never hit the market.
20:20 Venous vs arterial.
23:40 What do you see for the future of vascular surgery?
26:30 What business advice do you have for the next generation of Vascular Surgeons?
31:15 What do you like to do for fun?
……………………………………………...
Follow along on Twitter | @antegradeflow
Learn more on our website | www.antegradeflow.com
Looking for ways to market your practice? Check out our Sponsor www.paxmediainc.com
View all episodes
By CreativeWe’re joined by board certified Vascular Surgeon, Dr. Karthikeshwar Kasirajan. Dr. Kasi is a clinical professor of surgery at the University of Stanford School of Medicine and has conducted research into advances in minimally invasive procedures for stroke prevention and aneurysm management. Dr. Kasi has been the investigator in over 40 multicenter studies involving new stent grafts, thrombectomy catheters, and other advances in endovascular technology. In this part two episode with Dr. Kasi we hear him address issues with lack of pharmacogenomics testing, and the specific drug that causes the most frequent ER visits due to drug complications which can be avoided with proper testing! Listen in as we wrap up this part 2 conversation with Dr. Kasi about thrombectomy devices, techniques, and business advice for the next generation of Vascular Surgeons.
01:30 Mentors at the Cleveland Clinic.
03:00 Learning it wasn’t the norm to do pharmacogenomics testing.
05:50 How Medicare will not reimburse testing.
07:00 What is the number 1 cause for ER visits due to drug complications?
11:40 The need for genetic testing.
14:15 What has your experience been like leading the industry from the stage, to journals and the Operating Room?
19:00 Evolution of thrombectomy devices, including some that never hit the market.
20:20 Venous vs arterial.
23:40 What do you see for the future of vascular surgery?
26:30 What business advice do you have for the next generation of Vascular Surgeons?
31:15 What do you like to do for fun?
……………………………………………...
Follow along on Twitter | @antegradeflow
Learn more on our website | www.antegradeflow.com
Looking for ways to market your practice? Check out our Sponsor www.paxmediainc.com